Columbia Wanger Asset Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$18.1M Buy
338,665
+139,761
+70% +$7.38M 0.27% 148
2017
Q3
$8.87M Sell
198,904
-325,532
-62% -$14.8M 0.13% 178
2017
Q2
$25.5M Sell
524,436
-78,247
-13% -$4.61M 0.36% 114
2017
Q1
$43.6M Sell
602,683
-29,092
-5% -$1.92M 0.61% 64
2016
Q4
$36.1M Buy
631,775
+519,556
+463% +$47.6M 0.51% 87
2016
Q3
$14.4M Sell
112,219
-2,775
-2% -$355K 0.19% 162
2016
Q2
$14.3M Buy
+114,994
New +$13.2M 0.17% 164

Other funds holding ELGX

Columbia Wanger Asset Management's ELGX Position: Q4 2017 in Review

Columbia Wanger Asset Management increased its Endologix Inc (ELGX) stake by 70% in Q4 2017, buying an estimated $7.38M and bringing the position to 338,665 shares worth $18.1M. The position accounts for 0.27% of the portfolio, ranked #148.

Columbia Wanger Asset Management first reported a position in ELGX in Q2 2016 and has held it in 7 quarters since. The position peaked at $43.6M in Q1 2017. 103 funds tracked by Wall St. Rank hold ELGX as of Q4 2017.

  • Columbia Wanger Asset Management held 338,665 shares of Endologix Inc worth $18.1M as of Q4 2017.
  • Columbia Wanger Asset Management bought 139,761 Endologix Inc shares in Q4 2017, an estimated $7.38M.
  • Endologix Inc made up 0.27% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #148 holding.
  • Columbia Wanger Asset Management first reported a position in Endologix Inc in Q2 2016 and has held it in 7 quarters since.
  • Columbia Wanger Asset Management's Endologix Inc position peaked at $43.6M in Q1 2017.
  • 103 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.